The Pharmacokinetics and Toxicity of Morning vs. Evening Tobramycin Dosing for Pulmonary Exacerbations of Cystic Fibrosis: A Randomised Comparison

Journal of Cystic Fibrosis- Netherlands

doi 10.1016/j.jcf.2015.07.012

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Date

July 1, 2016

Authors

Publisher

Elsevier BV

Related search

Efficacy, Tolerance, and Pharmacokinetics of Once Daily Tobramycin for Pseudomonas Exacerbations in Cystic Fibrosis

Archives of Disease in Childhood

English

Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations

English

Morning vs Evening Dosing With Doxazosin in Benign Prostatic Hyperplasia: Efficacy and Safety

Prostate Cancer and Prostatic Diseases

Cancer Research

English

Inhaled Hypertonic Saline Reduces Pulmonary Exacerbations in Cystic Fibrosis

Respiratory Medicine

English

Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis

Frontiers in Pharmacology

English

Glucose Tolerance During Pulmonary Exacerbations in Children With Cystic Fibrosis

Multidisciplinary

English

Treatment of Pulmonary Exacerbations of Cystic Fibrosis Leads to Improved Antioxidant Status

European Respiratory Journal

Respiratory Medicine

English

Comparison of Morning and Evening/Night Dosing on the Efficacy of Escitalopram in Major Depressive Disorder at Naturalistic Setting

Chronobiology in Medicine

English

Blood mRNA Biomarkers for Detection of Treatment Response in Acute Pulmonary Exacerbations of Cystic Fibrosis

Respiratory Medicine

English